We are a clinical stage biopharmaceutical development company dedicated to identifying, in-licensing and developing promising therapeutic candidates. Our current pipeline consists of clinical and pre-clinical candidates spanning a variety of indications including: central nervous system diseases, infectious diseases, cardiovascular and autoimmune diseases.